Search results
Vertex Pharmaceuticals (VRTX) to Release Earnings on Monday
ETF DAILY NEWS· 8 hours agoVertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) will be announcing its earnings results after the market closes on Monday, May 6th. Analysts expect ...
Sigma Planning Corp Sells 1,061 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
ETF DAILY NEWS· 4 days agoSigma Planning Corp cut its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 37.3% during the 4th quarter, according to its ...
Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know
Zacks via Yahoo Finance· 4 days agoVertex Pharmaceuticals (VRTX) closed the most recent trading day at $397.70, moving -0.76% from the...
2 Top Growth Stocks to Buy Right Now and Hold Forever
Motley Fool via Yahoo Finance· 23 hours agoIf you're looking for top healthcare stocks to buy right now, here are two names you'll want to...
(VRTX) - Analyzing Vertex Pharmaceuticals's Short Interest By Benzinga
Investing.com· 4 days agoVertex Pharmaceuticals's (NYSE:VRTX) short percent of float has fallen 3.75% since its last report....
The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
Zacks via Yahoo Finance· 3 days agoStocks recently featured in the blog include: Biogen BIIB, Bristol Myers Squibb BMY, Incyte INCY and...
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?
Motley Fool via Yahoo Finance· 6 days agoVertex Pharmaceuticals (NASDAQ: VRTX) has long been known for its expertise in treating cystic...
Selling Buzz: Vertex Pharmaceuticals, Inc. [VRTX] SVP & Chief Accounting Officer Ambrose Kristen...
Knox Daily· 4 days agoInvestors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Vertex Pharmaceuticals, Inc. shares valued ...
EU expands cystic fibrosis treatment for infants with KALYDECO By Investing.com
Investing.com· 3 days agoVertex Pharmaceuticals (NASDAQ:VRTX) has announced the European Commission's approval to expand the...
Vertex Pharmaceuticals in T1D Licensing Pact With TreeFrog Therapeutics
Market Watch· 6 days agoVertex Pharmaceuticals has struck an exclusive licensing agreement with privately held TreeFrog Therapeutics in a bid to bolster production of its cell ...